Zenith Capital Corp. (ZHCLF) Stock

No profile data available.

About Zenith Capital Corp. (ZHCLF)

Zenith Capital Corp. (ZHCLF) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Calgary, Canada.

Its market capitalization was $16.10 million as of October 8, 2026.

Figures from company filings and market data; latest fiscal year ended April 30, 2022; market data as of October 8, 2026.

Sector: Healthcare
Industry: Multi-Therapeutic Drug Manufacturing
Headquarters: Calgary, Canada
Exchange: OTC Markets OTCPK
Market cap: $16.10 million (October 8, 2026)

Frequently asked questions

What does Zenith Capital do?

, a biotechnology investment company, develops bromodomain (BET) inhibitors for the treatment of cancer and other disorders with unmet medical needs in Canada.

What is Zenith Capital's market cap?

$16.10 million as of October 8, 2026.

What companies are similar to Zenith Capital?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include BeyondSpring Inc. (BYSI), inTerra Resources Corp (ITRX), Jasper Therapeutics, Inc. (JSPR), Vyome Holdings, Inc. (HIND).

Similar companies

BeyondSpring (BYSI)inTerra Resources (ITRX)Jasper Therapeutics (JSPR)Vyome (HIND)Aida Pharmaceuticals (AIDA)Fluent (CNTMF)

Industry and sector

Pharmaceutical Preparation Manufacturing industry Manufacturing sector Healthcare sector data Stock screener Search all stocks

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Metric	Value	Period
Total Revenue	9999999999999	FY2099
Net Income	-8888888888	FY2099
Earnings Per Share	123.456789	FY2099
Gross Profit	7777777777	FY2099
Operating Income	6666666666	FY2099